Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/199582
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBantulà, Marina-
dc.contributor.authorTubita, Valeria-
dc.contributor.authorRoca Ferrer, Jordi-
dc.contributor.authorMullol i Miret, Joaquim-
dc.contributor.authorValero, Antonio-
dc.contributor.authorBobolea, Irina-
dc.contributor.authorPascal i Capdevila, Mariona-
dc.contributor.authorHollanda Ramírez, Ana M. de-
dc.contributor.authorVidal, Josep-
dc.contributor.authorPicado Vallés, César-
dc.contributor.authorArismendi, Ebymar-
dc.date.accessioned2023-06-21T09:57:40Z-
dc.date.available2023-06-21T09:57:40Z-
dc.date.issued2022-06-29-
dc.identifier.issn2077-0383-
dc.identifier.urihttp://hdl.handle.net/2445/199582-
dc.description.abstractObesity and asthma are associated with systemic inflammation maintained by mediators released by adipose tissue and lung. This study investigated the inflammatory serum mediator profile in obese subjects (O) (n = 35), non-obese asthma (NOA) patients (n = 14), obese asthmatics (OA) (n = 21) and healthy controls (HC) (n = 33). The effect of weight loss after bariatric surgery (BS) was examined in 10 OA and 31 O subjects. We analyzed serum markers including leptin, adiponectin, TGF-?1, TNFR2, MCP-1, ezrin, YKL-40, ST2, IL-5, IL-9, and IL-18. Compared with HC subjects, the O group showed increased levels of leptin, TGF-?1, TNFR2, MCP-1, ezrin, YKL-40, and ST2; the OA group presented increased levels of MCP-1, ezrin, YKL-40, and IL-18, and the NOA group had increased levels of ezrin, YKL-40, IL-5, and IL-18. The higher adiponectin/leptin ratio in NOA with respect to OA subjects was the only significant difference between the two groups. IL-9 was the only cytokine with significantly higher levels in OA with respect to O subjects. TNFR2, ezrin, MCP-1, and IL-18 concentrations significantly decreased in O subjects after BS. O, OA, and NOA showed distinct patterns of systemic inflammation. Leptin and adiponectin are regulated in asthma by obesity-dependent and-independent mechanisms. Combination of asthma and obesity does not result in significant additive effects on circulating cytokine levels. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.-
dc.format.extent19 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/jcm11133782-
dc.relation.ispartofJournal Of Clinical Medicine, 2022, vol. 11, num. 13-
dc.relation.urihttps://doi.org/10.3390/jcm11133782-
dc.rightscc by (c) Bantulà, Marina et al, 2022-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)-
dc.subject.classificationAsma-
dc.subject.classificationObesitat-
dc.subject.otherAsthma-
dc.subject.otherObesity-
dc.titleDifferences in Inflammatory Cytokine Profile in Obesity-Associated Asthma: Effects of Weight Loss-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2023-06-20T10:44:35Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina9330620-
dc.identifier.pmid35807067-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
Differences in Inflammatory Cytokine Profile in_ClinicalMedicine.pdf1.05 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons